Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIP for Hypoglycemia in Type 1 Diabetes
NCT03556098Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of glucose-dependent insulinotropic polypeptide[1-42] in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Plasma glucose concentration. Started Feb 2019; status: completed.
02
Drugs
glucose-dependent insulinotropic polypeptide[1-42]
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03556098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556098.